Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study hypothesis is that integrated medicine consultation and treatment provided within the oncology department may improve patients' concerns and well-being.
In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS established the Integrative Oncology Program with the goal of addressing patient concerns and improving quality of life parameters during chemotherapy and advanced disease. The study is purposed to assess concerns, needs and perspectives of patients referred to integrative consultation during chemotherapy and/or advanced cancer; to characterize social demographic and health parameters of patients who consult or avoid integrative medicine consultation; to document complementary medicine use prior and during consultation; to assess if complementary medicine consultation and treatment improve patient's concerns and well-being; and to assess oncology provider and integrative practitioner communications issues concerning integrative care.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Complementary medicine counseling | Experimental | Patients receiving chemotherapy who are referred by their oncology provider to complementary medicine consultation and treatment provided in addition to conventional supportive care |
|
| Conventional supportive care | Active Comparator | Patients receiving conventional supportive care |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Complementary medicine consultation and treatment | Other | Patients receiving chemotherapy will be referred by their oncology provider to complementary medicine (CM) consultation and treatment provided in addition to conventional supportive care.CM consultation will include assessment of patients' concerns and well-being, current CM use (including herbal and nutritional supplements), and construction of CM treatment based on efficacy and safety considerations. |
| Measure | Description | Time Frame |
|---|---|---|
| MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire | Assessing patients'concerns and Wellbeing as well as narrative assessment of integrative care outcomes | 6-12 weeks(+follow-up 4 months) |
| ESAS (Edmonton Symptom Assessment Scale)questionnaire | Assessing the severity of 10 leading symptoms and well-being | 6-12 weeks(+follow-up 4 months) |
| EORTC QLQ-C30 | The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing the health related quality of life of cancer patients. The questionnaire includes functional and symptom scales. | 6-12 weeks(+follow-up 4 months) |
| Measure | Description | Time Frame |
|---|---|---|
| FACIT-Sp-12 questionnaire | Assessing patients' spiritual well-being | 2-4 months |
| Attitudes concerning complementary medicine | Assessment of patients' attitudes concerning complementary medicine (CM)safety and efficacy, health beliefs concerning mind-body interactions, and willingness to receive CM treatments |
| Measure | Description | Time Frame |
|---|---|---|
| Complementary medicine side-effects documentation | Documentation in registry protocol of patients' reported side-effects concerning complementary medicine treatments | 6-12 weeks(+follow-up 4 months) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eran Ben-Arye, MD | Clalit Health Services | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lin Zebulon and Carmel Medical centers | Recruiting | Haifa | 35152 | Israel |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41843227 | Derived | Kassem S, Gressel O, Samuels N, Stein N, Glaser B, Ben-Arye E. The impact of integrative medicine on quality of life in patients with diabetes mellitus and cancer. Support Care Cancer. 2026 Mar 17;34(4):335. doi: 10.1007/s00520-026-10511-6. | |
| 41147326 | Derived | Ben-Arye E, Greenberg D, Samuels N, Lopez AM, Simon-Tuval T. Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization. Integr Cancer Ther. 2025 Jan-Dec;24:15347354251387955. doi: 10.1177/15347354251387955. Epub 2025 Oct 28. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Patients receiving conventional supportive care | Other | Patients receiving chemotherapy will be offered assessment of their concerns and well-being as well as their current complementary medicine (CM) use (including herbal and nutritional supplements). Patients in this arm study will receive conventional supportive care with no added CM consultation or treatment. |
|
| 6-12 weeks |
| 37787815 | Derived | Hauzer M, Grimberg R, Samuels N, Keshet Y, Mordechai A, Dagash J, Ben-Arye E. Exploring primary care physician feedback following an integrative oncology consultation. Support Care Cancer. 2023 Oct 3;31(10):606. doi: 10.1007/s00520-023-08079-6. |
| 34435403 | Derived | Ben-Arye E, Elly M, Gressel O, Reshef A, Shani Md M, Stein N, Saliba W, Samuels N. Exploring the effectiveness of a patient-tailored integrative oncology program on emotional distress during chemotherapy for localized cancer. Psychooncology. 2022 Feb;31(2):207-218. doi: 10.1002/pon.5794. Epub 2021 Aug 26. |
| 28710110 | Derived | Kerner H, Samuels N, Ben Moshe S, Sharabi IS, Ben-Arye E. Impact of a patient-tailored complementary/integrative medicine programme on disturbed sleep quality among patients undergoing chemotherapy. BMJ Support Palliat Care. 2020 Sep;10(3):e21. doi: 10.1136/bmjspcare-2017-001351. Epub 2017 Jul 14. |
| 27169571 | Derived | Sharabi IS, Levin A, Schiff E, Samuels N, Agour O, Tapiro Y, Lev E, Keinan-Boker L, Ben-Arye E. Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel. Support Care Cancer. 2016 Oct;24(10):4345-55. doi: 10.1007/s00520-016-3274-3. Epub 2016 May 11. |
| 26361759 | Derived | Ben-Arye E, Keshet Y, Shahbar IM, Aharonson ML, Preis L, Agour O, Schiff E, Samuels N. The kitchen as therapy: qualitative assessment of an integrative cuisine workshop for patients undergoing chemotherapy. Support Care Cancer. 2016 Apr;24(4):1487-95. doi: 10.1007/s00520-015-2934-z. Epub 2015 Sep 11. |
| 25752885 | Derived | Ben-Arye E, Samuels N, Schiff E, Raz OG, Sharabi IS, Lavie O. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy. Support Care Cancer. 2015 Dec;23(12):3411-9. doi: 10.1007/s00520-015-2690-0. Epub 2015 Mar 10. |
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided